Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

335
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
335
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

2.0K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

295
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
295
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

1.5K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.5K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

551
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
551
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

294
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
294

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized processing of explanted hearts after stereotactic arrhythmia radiotherapy (Bio-STAR): a STOPSTORM framework and first human findings.

European heart journal open·2026
Same author

EACVI Survey on the Current Multi-Modality Imaging Practice in Patients with Tricuspid Regurgitation.

European heart journal. Imaging methods and practice·2026
Same author

History of Cardiology: ESC Congress 2025, Madrid.

European heart journal·2026
Same author

Risk of developing autoimmune and immune mediated disease following a diagnosis of myocarditis - a Danish nationwide register-based cohort study.

International journal of cardiology·2025
Same author

Spondylodiscitis and infective endocarditis: A retrospective cohort analysis of clinical outcomes, microbiological profiles, and mortality in 312 patients.

Brain & spine·2025
Same author

Long-Term Outcomes of Indirect Annuloplasty for Functional Mitral Regurgitation: Interim Results From the CINCH Registry.

Structural heart : the journal of the Heart Team·2025

Related Experiment Video

Updated: Mar 7, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

[Electrophysiologic procedure complications in the elderly].

Dietrich Pfeiffer1, Martin Neef2, Daniel Jurisch2

  • 1Abt. Kardiologie & Angiologie, Department für Innere Medizin, Neurologie und Dermatologie, Universität Leipzig, Liebigstr. 20, 04103, Leipzig, Deutschland. dietrich.pfeiffer@medizin.uni-leipzig.de.

Herzschrittmachertherapie & Elektrophysiologie
|February 11, 2017
PubMed
Summary

Patient age is not a barrier to electrophysiologic interventions. Individual risk assessment by an experienced cardiologist is crucial for determining procedural suitability and managing potential complications in all patients.

Keywords:
Catheter ablationGeriatricsInformed consentPacemaker, artificialResynchronization

More Related Videos

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.5K
Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

21.4K

Related Experiment Videos

Last Updated: Mar 7, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.5K
Programmed Electrical Stimulation in Mice
07:29

Programmed Electrical Stimulation in Mice

Published on: May 26, 2010

21.4K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Interventions

Background:

  • Published registries offer limited data on age-specific complication rates in electrophysiology.
  • Patient subgroups, procedural experience, and evolving indications complicate registry interpretation.
  • Elderly patients with poor prognoses are often excluded from electrophysiologic studies, limiting real-world applicability.

Purpose of the Study:

  • To evaluate the relevance of patient age in the context of electrophysiologic intervention complications.
  • To determine if age should be a limiting factor for electrophysiologic procedures.
  • To emphasize the importance of individualized risk assessment.

Main Methods:

  • Review of published registry data and meta-analyses of randomized trials.
  • Analysis of factors influencing complication rates in electrophysiologic procedures.
  • Comparison of data from clinical trials versus daily practice.

Main Results:

  • Published data on age-dependent complications are often limited and difficult to interpret.
  • Randomized trials may exclude elderly patients, not reflecting real-world scenarios.
  • Patient age itself is not a predictor of complications; individual risk assessment is key.

Conclusions:

  • There is no inherent age limit for undergoing electrophysiologic interventions.
  • Individualized risk assessment by an experienced cardiologist is essential for all patients.
  • Informed consent and personalized risk evaluation are paramount for procedural safety.